We are sorry, the requested page was not found. Please, try another query.
Home
Go to catalog
Українська
Русский
English
The Information in this section is intended for healthcare professionals only.
Please confirm that you are a healthcare professional.
Yes
No
Cookies
This site uses cookies for site interaction analysis with a purpose of service quality enhancing and uninterrupted site work. More details in
Cookies Policy
Accept
Restrictions on obtaining information
You find yourself in a specialized publication, which is part of the site of PJSC Pharmaceutical company Darnitsa and is intended for medical institutions and doctors (the “certified medical specialists”) and contains professional specialized information about drugs, including prescription medicines, in particular, about their name, characteristics, methods of application, medicinal properties, possible side effects, possible contraindications, and other professional specialized information.
Information about preparations, including prescription drugs of PJSC Pharmaceutical company Darnitsa, is intended solely for familiarizing and is not a guide for self-diagnosis or treatment.
Can you confirm that you are a certified medical professional and have read this information restriction?
Confirm
Don't confirm
Research
The research presented on this page is not an exhaustive list of the company's research
05 June 2023
Summary of bioequivalence study for Darfen, coated tablets (ibuprofen)
17 February 2023
Summary of therapeutic equivalence study results for Darfen Gel, gel (ibuprofen and levomenthol)
17 February 2023
Summary of therapeutic equivalence study results for Darfen Gel, gel (ibuprofen and levomenthol)
25 January 2023
Summary of bioequivalence study for EFEZ, 25 mg eplerenone film-coated tablets; 50 mg eplerenone film-coated tablets
24 January 2023
Summary of bioequivalence study for TIARA SOLO®, 80 mg valsartan film-coated tablets; 160 mg valsartan film-coated tablets
20 January 2023
Summary of bioequivalence study for PERINDOPRES DUO, 4 mg perindopril tert-butylamine / 1.25 mg indapamide tablets; 8 mg perindopril tert-butylamine / 2.5 mg indapamide tablets
Specialized edition for medical institutions and doctors.